Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Harry Pinson

Faculty of Medicine and Health Sciences > Department of Human Structure and Repair

ORCID iD: 0000-0002-0650-4213

Add to list
- Journal Article
- A2
- open access
Temporal muscle measurements as predictor for outcome in a cohort of IDH-wildtype glioblastoma patients

Harry Pinson (UGent) , C. De Rudder, L De Backer, A. Van Sinay, Tom Boterberg (UGent) and Giorgio Hallaert (UGent)

(2026) BRAIN AND SPINE. 6.
Add to list
Repurposing itraconazole and pyrimethamine as a combinatorial treatment for glioblastoma

Thibault Lootens (UGent) , Anne-Sophie Bamelis (UGent) , Jelle Vandersteene (UGent) , Harry Pinson (UGent) , Sam Ernst (UGent) , Tom Boterberg (UGent) , Vanessa Vermeirssen (UGent) , Olivier De Wever (UGent) , Frederik De Smet and Robrecht Raedt (UGent)

(2025) NEURO-ONCOLOGY. 27(Suppl. 5). p.v353-v353
Add to list
Repurposing itraconazole and pyrimethamine with temozolomide as a combinatorial treatment for glioblastoma

Thibault Lootens (UGent) , Jelle Vandersteene (UGent) , Harry Pinson (UGent) , Sam Ernst (UGent) , Tom Boterberg (UGent) , Vanessa Vermeirssen (UGent) , Olivier De Wever (UGent) , Frederik De Smet and Robrecht Raedt (UGent)

(2025) OncoPoint Symposium, 11th, Abstracts.
Add to list
Repurposing itraconazole and pyrimethamine with temozolomide as a combinatorial treatment for glioblastoma

Thibault Lootens (UGent) , Jelle Vandersteene (UGent) , Harry Pinson (UGent) , Tom Boterberg (UGent) , Vanessa Vermeirssen (UGent) , Olivier De Wever (UGent) , Frederik De Smet and Robrecht Raedt (UGent)

(2024) NEURO-ONCOLOGY. In Neuro-Oncology 26(Suppl. 5). p.v135-v135
Add to list
Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era

Harry Pinson (UGent) , Geert Silversmit, Dimitri Vanhauwaert (UGent) , Katrijn Vanschoenbeek, Jean-Pierre Kalala Okito (UGent) , Steven De Vleeschouwer, Tom Boterberg (UGent) and Cindy De Gendt

(2024) NEURO-ONCOLOGY. 26(1). p.191-202
Add to list
Cancer registration, molecular marker status and adherence to the WHO 2016 classification of pathology reports for glioma diagnosed during 2017-2019 in Belgium

Dimitri Vanhauwaert (UGent) , Harry Pinson (UGent) , Katrijn Vanschoenbeek, Franceska Dedeurwaerdere (UGent) , Cindy De Gendt, Tom Boterberg (UGent) and Steven De Vleeschouwer

(2023) PATHOBIOLOGY. 90(6). p.365-376
Add to list
- Conference Paper
- C3
Cancer registration and adherence to the WHO 2016 classification of pathology reports for astrocytic tumors in Belgium from 2017 to 2019

D J Vanhauwaert, Harry Pinson (UGent) , F Dedeurwaerdere, A Leloup, K Vanschoenbeek, C De Gendt, H De Schutter, S De Vleeschouwer and Tom Boterberg (UGent)

(2022) NEURO-ONCOLOGY. In Neuro-Oncology 24(Suppl. 2). p.ii63-ii63
Add to list
Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey

Dimitri Vanhauwaert (UGent) , Harry Pinson (UGent) , Caroline Sweldens, Stephanie Du Four, Liesbet Van Eycken, Harlinde De Schutter, Steven De Vleeschouwer, Tom Boterberg (UGent) and [missing] QINO consortium

(2022) JOURNAL OF NEURO-ONCOLOGY. 157(2). p.365-376
Add to list
The supplementary motor area syndrome : a neurosurgical review

Harry Pinson (UGent) , Jeroen Van Lerbeirghe, Dimitri Vanhauwaert, Olivier Van Damme, Giorgio Hallaert (UGent) and Jean-Pierre Kalala Okito (UGent)

(2022) NEUROSURGICAL REVIEW. 45. p.81-90
Add to list
- Conference Paper
- C3
Quality indicators in neuro-oncology : modified Delphi process for the development of a quality indicator set for assessment of glioma care

D J Vanhauwaert, Harry Pinson (UGent) , H De Schutter, E Van Eycken, S De Vleeschouwer and Tom Boterberg (UGent)

(2021) NEURO-ONCOLOGY. In Neuro-Oncology 23(Suppl. 2). p.42-42

1
2
3

Next →